sulfinpyrazone has been researched along with Migraine Disorders in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalessio, DJ | 2 |
| Otis, S | 1 |
| Smith, R | 1 |
2 other studies available for sulfinpyrazone and Migraine Disorders
| Article | Year |
|---|---|
Vasomotor phenomena, platelet antagonism and migraine therapy.
Topics: Aspirin; Ergotamine; Fenoprofen; Humans; Migraine Disorders; Platelet Aggregation; Serotonin; Sulfin | 1978 |
Use of platelet antagonists in the treatment of migraine.
Topics: Aspirin; Blood Platelets; Dipyridamole; Migraine Disorders; Platelet Aggregation; Sulfinpyrazone | 1976 |